Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.21.2
Stockholders' Equity - Restricted Stock (Details) - Unvested restricted stock
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares, Nonvested beginning balance | shares 3,869,896
Number of shares, Granted | shares 919,012
Number of shares, Vested | shares (548,040)
Number of shares, Nonvested ending balance | shares 4,240,868
Weighted Average Exercise Price, Nonvested beginning balance | $ / shares $ 3.61
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.70
Weighted Average Grant Date Fair Value, Vested | $ / shares 4.17
Weighted Average Exercise Price, Nonvested ending balance | $ / shares $ 3.34